news
Activating the protein channel TRPML1 induced selective melanoma cell death…
25 October 2021 | By Anna Begley (Drug Target Review)
Activating the protein channel TRPML1 induced selective melanoma cell death while sparing normal cells, suggesting a potential pathway for new cancer therapies.